ATE157653T1 - Piperidin-derivate - Google Patents
Piperidin-derivateInfo
- Publication number
- ATE157653T1 ATE157653T1 AT92302751T AT92302751T ATE157653T1 AT E157653 T1 ATE157653 T1 AT E157653T1 AT 92302751 T AT92302751 T AT 92302751T AT 92302751 T AT92302751 T AT 92302751T AT E157653 T1 ATE157653 T1 AT E157653T1
- Authority
- AT
- Austria
- Prior art keywords
- piperidine derivatives
- piperidine
- trisubstitutedpiperidinyl
- alkylcarboxylates
- carboxylates
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000003887 narcotic antagonist Substances 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67704291A | 1991-03-29 | 1991-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE157653T1 true ATE157653T1 (de) | 1997-09-15 |
Family
ID=24717068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92302751T ATE157653T1 (de) | 1991-03-29 | 1992-03-27 | Piperidin-derivate |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0506478B1 (de) |
| JP (1) | JP3056321B2 (de) |
| KR (1) | KR100229117B1 (de) |
| CN (1) | CN1041309C (de) |
| AT (1) | ATE157653T1 (de) |
| AU (1) | AU644051B2 (de) |
| BR (1) | BR9201084A (de) |
| CY (1) | CY2062B1 (de) |
| CZ (1) | CZ284993B6 (de) |
| DE (1) | DE69221919T2 (de) |
| DK (1) | DK0506478T3 (de) |
| ES (1) | ES2106825T3 (de) |
| FI (1) | FI104323B1 (de) |
| GR (1) | GR3025494T3 (de) |
| HK (1) | HK1000441A1 (de) |
| HU (2) | HU221316B1 (de) |
| IE (1) | IE921003A1 (de) |
| IL (1) | IL101382A (de) |
| MX (1) | MX9201356A (de) |
| NO (1) | NO178398C (de) |
| NZ (1) | NZ242117A (de) |
| RU (1) | RU2076863C1 (de) |
| YU (1) | YU30492A (de) |
| ZA (1) | ZA922180B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5434171A (en) * | 1993-12-08 | 1995-07-18 | Eli Lilly And Company | Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
| US6207685B1 (en) * | 1996-12-06 | 2001-03-27 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Therapeutic application of a thienycyclohexylamine derivative |
| GB9725114D0 (en) * | 1997-11-28 | 1998-01-28 | Pfizer Ltd | Treatment of pruritus |
| GB9810671D0 (en) * | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
| TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
| US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
| EP2517710B1 (de) * | 2000-02-08 | 2015-03-25 | Euro-Celtique S.A. | Missbrauchssichere orale Opioidagonisten-Formulierungen |
| PL368919A1 (en) | 2001-10-22 | 2005-04-04 | Pfizer Products Inc. | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| DE10161818A1 (de) | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | Substituierte 1,5-Diaminopentan-3-ol-Verbindungen |
| RU2224518C1 (ru) * | 2003-02-10 | 2004-02-27 | Дулькис Мария Дмитриевна | Жидкая лекарственная форма налтрексона |
| MXPA05011070A (es) * | 2003-04-14 | 2005-12-12 | Pfizer Prod Inc | Derivados de 3-azabiciclo [3.2.1] octano. |
| US6992090B2 (en) * | 2003-06-16 | 2006-01-31 | Adolor Corporation | Substituted piperidine compounds and methods of their use |
| US7910593B2 (en) * | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| US7700626B2 (en) * | 2004-06-04 | 2010-04-20 | Adolor Corporation | Compositions containing opioid antagonists |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| CN100383121C (zh) * | 2006-03-07 | 2008-04-23 | 天津泰普药品科技发展有限公司 | 阿韦苄酯化合物及其制备方法和以该化合物制备阿韦莫哌的工艺 |
| KR101453107B1 (ko) | 2006-04-21 | 2014-10-27 | 디에스엠 아이피 어셋츠 비.브이. | 오피오이드 수용체 길항제의 용도 |
| CN101838233A (zh) * | 2010-05-27 | 2010-09-22 | 北京万全阳光医学技术有限公司 | 一种阿维莫泮关键中间体的制备方法 |
| CN101967118B (zh) * | 2010-10-14 | 2013-01-30 | 成都苑东药业有限公司 | 爱维莫潘的制备方法 |
| CN105820106B (zh) * | 2015-01-07 | 2018-11-09 | 上海医药工业研究院 | 爱维莫潘中间体的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3884916A (en) * | 1971-03-30 | 1975-05-20 | Janssen Pharmaceutica Nv | 2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides |
| US4115400A (en) * | 1976-05-27 | 1978-09-19 | Eli Lilly And Company | 1-Azoniabicyclo[3.1.0]hexanes |
| IL86061A (en) * | 1987-04-16 | 1992-07-15 | Lilly Co Eli | Derivatives of trans-3,4-isomer of 4-methyl-4-phenyl-piperidines,process for their preparation and pharmaceutical compositions containing them |
| FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
-
1992
- 1992-03-25 CZ CS92902A patent/CZ284993B6/cs not_active IP Right Cessation
- 1992-03-25 NZ NZ242117A patent/NZ242117A/en not_active IP Right Cessation
- 1992-03-25 ZA ZA922180A patent/ZA922180B/xx unknown
- 1992-03-26 MX MX9201356A patent/MX9201356A/es unknown
- 1992-03-26 IL IL101382A patent/IL101382A/xx not_active IP Right Cessation
- 1992-03-26 HU HU9201013A patent/HU221316B1/hu not_active IP Right Cessation
- 1992-03-26 YU YU30492A patent/YU30492A/sh unknown
- 1992-03-26 NO NO921182A patent/NO178398C/no not_active IP Right Cessation
- 1992-03-27 KR KR1019920005104A patent/KR100229117B1/ko not_active Expired - Fee Related
- 1992-03-27 EP EP92302751A patent/EP0506478B1/de not_active Expired - Lifetime
- 1992-03-27 IE IE100392A patent/IE921003A1/en unknown
- 1992-03-27 JP JP4070790A patent/JP3056321B2/ja not_active Expired - Fee Related
- 1992-03-27 AT AT92302751T patent/ATE157653T1/de not_active IP Right Cessation
- 1992-03-27 FI FI921345A patent/FI104323B1/fi not_active IP Right Cessation
- 1992-03-27 AU AU13880/92A patent/AU644051B2/en not_active Ceased
- 1992-03-27 ES ES92302751T patent/ES2106825T3/es not_active Expired - Lifetime
- 1992-03-27 RU SU925011276A patent/RU2076863C1/ru active
- 1992-03-27 DK DK92302751.0T patent/DK0506478T3/da active
- 1992-03-27 DE DE69221919T patent/DE69221919T2/de not_active Expired - Lifetime
- 1992-03-27 BR BR929201084A patent/BR9201084A/pt not_active Application Discontinuation
- 1992-03-28 CN CN92102213A patent/CN1041309C/zh not_active Expired - Fee Related
-
1995
- 1995-06-22 HU HU95P/P00379P patent/HU211622A9/hu unknown
-
1997
- 1997-10-20 HK HK97101955A patent/HK1000441A1/en not_active IP Right Cessation
- 1997-11-26 GR GR970403143T patent/GR3025494T3/el unknown
-
1998
- 1998-06-12 CY CY9802062A patent/CY2062B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE157653T1 (de) | Piperidin-derivate | |
| DE69531331D1 (de) | Phenylpiperidinderivate als neurokinin antagonists | |
| FI960727L (fi) | Neurokiniiniantagonisteina käyttökelpoiset heterosyklit | |
| FI941022L (fi) | Spirosykliset piperidiinijohdannaiset | |
| DE69232003D1 (de) | Benzanilidderivate als 5-HT1D-Antagonisten | |
| DE69431604D1 (de) | Benzofuranderivate als tachykininantagonisten | |
| DE69326160D1 (de) | 4-carboxamidopiperidinderivate, zwischenprodukte und verwendung als neurokinin antagonisten | |
| FI942635A7 (fi) | Piperatsiinijohdannaiset 5HT1A-antagonisteina | |
| NO930306L (no) | Nye 1,4-dihydropyridinderivater | |
| FI963786L (fi) | Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina | |
| CA2064373A1 (en) | Piperidine derivatives | |
| FI923664A7 (fi) | Piperidiinijohdannaisia | |
| DE69216260D1 (de) | Piperidinderivate | |
| DE58907381D1 (de) | Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin. | |
| DK382788A (da) | 4-amino-substituerede 1,2-dihydroxy-naphthalen-derivater | |
| IT8921380A0 (it) | Composti piperazin piperidinici atti all'impiego come stabilizzanti per materiali organici. | |
| FI944655A7 (fi) | Uudet 2,3-dihydro-2,2,4,6,7-penta-alkyyli-5-bentsofuranolit | |
| FI885391A7 (fi) | 1,4-disubstituoituja piperidinyyliyhdisteitä | |
| KR950700297A (ko) | 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist) | |
| MY111366A (en) | Piperdine derivatives. | |
| FI923201A7 (fi) | 3,4-dehydropiperidiinijohdannaisia | |
| DE69200943D1 (de) | Derivate von Piperidin. | |
| FI914500A7 (fi) | Allergian vastaisia dihydropyridiinejä | |
| FR2617165B1 (fr) | Derives du dimethyl-2, 2 chromannol-3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |